Tuberculosis future or investigational therapies: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Future investigations== | ==Future investigations== | ||
In future therapies the following questions must be pondered on . | In future therapies the following questions must be pondered on The cost effectiveness in various tubercular control interventions in Africa region is give below. <ref name=Future therapy>{{cite web | title = Future therapy| url = http://erj.ersjournals.com/content/20/36_suppl/87S.full}}</ref> | ||
. | |||
1) How can we shorten chemotherapy? | 1) How can we shorten chemotherapy? | ||
Revision as of 21:49, 24 September 2014
|
Tuberculosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tuberculosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Tuberculosis future or investigational therapies |
|
Tuberculosis future or investigational therapies in the news |
|
Risk calculators and risk factors for Tuberculosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Future investigations
In future therapies the following questions must be pondered on The cost effectiveness in various tubercular control interventions in Africa region is give below. .
1) How can we shorten chemotherapy?
2)How can the interval between the therapy reduced ?
3) How can new drugs be developed ?
4) What is the best therapy for tuberculosis with HIV ?
5) Role of immunomodulation